Sectors & IndustriesHealthcare

Best Healthcare Stocks to Buy Now (2023)

Top healthcare stocks in 2023 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

According to Zen Score, the 3 best healthcare stocks to buy right now are:

Arcturus Therapeutics Holdings (NASDAQ:ARCT) is the top healthcare stock with a Zen Score of 75, which is 48 points higher than the healthcare sector average of 27. It passed 24 out of 33 due diligence checks and has strong fundamentals. Arcturus Therapeutics Holdings has seen its stock return 29.94% over the past year, overperforming other healthcare stocks by 47 percentage points.

Arcturus Therapeutics Holdings has an average 1 year price target of $58.67, an upside of 155.52% from Arcturus Therapeutics Holdings's current stock price of $22.96.

Arcturus Therapeutics Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Arcturus Therapeutics Holdings, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Inmode (NASDAQ:INMD) is the second best healthcare stock with a Zen Score of 71, which is 44 points higher than the healthcare sector average of 27. It passed 23 out of 33 due diligence checks and has strong fundamentals. Inmode has seen its stock lose -35.57% over the past year, underperforming other healthcare stocks by -19 percentage points.

Inmode has an average 1 year price target of $40.25, an upside of 70.41% from Inmode's current stock price of $23.62.

Inmode stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Inmode, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Voyager Therapeutics (NASDAQ:VYGR) is the third best healthcare stock with a Zen Score of 66, which is 39 points higher than the healthcare sector average of 27. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock return 18.66% over the past year, overperforming other healthcare stocks by 36 percentage points.

Voyager Therapeutics has an average 1 year price target of $16.00, an upside of 115.05% from Voyager Therapeutics's current stock price of $7.44.

Voyager Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Voyager Therapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 79 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

Healthcare Services Group (NASDAQ:HCSG) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 5.87%. Healthcare Services Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Healthcare Services Group's dividend has shown consistent growth over the last 10 years.

Healthcare Services Group's dividend payout ratio of 48.9% indicates that its dividend yield is sustainable for the long-term.

Kineta (NASDAQ:KA) has an annual dividend yield of 230.12%, which is 224 percentage points higher than the healthcare sector average of 5.87%.

Kineta's dividend payout ratio of -16,683.3% indicates that its high dividend yield might not be sustainable for the long-term.

Medigus (NASDAQ:MDGS) has an annual dividend yield of 27.96%, which is 22 percentage points higher than the healthcare sector average of 5.87%.

Medigus's dividend payout ratio of -9.8% indicates that its high dividend yield might not be sustainable for the long-term.

Healthcare stocks were down -0.72% in the last day, and up 2.78% over the last week. Ibio was the among the top losers in the healthcare sector, dropping -50% yesterday.

iBio shares are trading lower after the company announced pricing of a $4.5 million public offering.

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

Arcturus Therapeutics Holdings (NASDAQ:ARCT) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Arcturus Therapeutics Holdings has a valuation score of 100, which is 72 points higher than the healthcare sector average of 28. It passed 7 out of 7 valuation due diligence checks.

Arcturus Therapeutics Holdings's stock has gained 29.94% in the past year. It has overperformed other stocks in the healthcare sector by 47 percentage points.

Inmode (NASDAQ:INMD) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 72 points higher than the healthcare sector average of 28. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -35.57% in the past year. It has underperformed other stocks in the healthcare sector by -19 percentage points.

Voyager Therapeutics (NASDAQ:VYGR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 72 points higher than the healthcare sector average of 28. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has gained 18.66% in the past year. It has overperformed other stocks in the healthcare sector by 36 percentage points.